Poudel S, Gupta S, Saigal S
J Clin Exp Hepatol. 2024; 14(3):101345.
PMID: 38450290
PMC: 10912712.
DOI: 10.1016/j.jceh.2024.101345.
Lou B, Ma G, Lv F, Yuan Q, Xu F, Dong Y
Front Immunol. 2021; 12:710528.
PMID: 34777339
PMC: 8579009.
DOI: 10.3389/fimmu.2021.710528.
Ronca V, Wootton G, Milani C, Cain O
Front Immunol. 2020; 11:2155.
PMID: 32983177
PMC: 7492390.
DOI: 10.3389/fimmu.2020.02155.
Thomson A, Vionnet J, Sanchez-Fueyo A
Nat Rev Gastroenterol Hepatol. 2020; 17(12):719-739.
PMID: 32759983
DOI: 10.1038/s41575-020-0334-4.
Kahn J, Schemmer P
Visc Med. 2019; 34(6):444-448.
PMID: 30675491
PMC: 6341346.
DOI: 10.1159/000493889.
The relationship between HBcrAg and HBV reinfection in HBV related post-liver transplantation patients.
Urabe A, Imamura M, Tsuge M, Kan H, Fujino H, Fukuhara T
J Gastroenterol. 2016; 52(3):366-375.
PMID: 27422771
DOI: 10.1007/s00535-016-1240-y.
Application of contrast-enhanced ultrasound after liver transplantation: Current status and perspectives.
Ren J, Wu T, Zheng B, Tan Y, Zheng R, Chen G
World J Gastroenterol. 2016; 22(4):1607-16.
PMID: 26819526
PMC: 4721992.
DOI: 10.3748/wjg.v22.i4.1607.
Application of nucleoside analogues to liver transplant recipients with hepatitis B.
Song Z, Cui Y, Zheng W, Teng D, Zheng H
World J Gastroenterol. 2015; 21(42):12091-100.
PMID: 26576094
PMC: 4641127.
DOI: 10.3748/wjg.v21.i42.12091.
Change of strategies and future perspectives against hepatitis B virus recurrence after liver transplantation.
Ishigami M, Ogura Y, Hirooka Y, Goto H
World J Gastroenterol. 2015; 21(36):10290-8.
PMID: 26420956
PMC: 4579876.
DOI: 10.3748/wjg.v21.i36.10290.
Anthony Cerami Award in Translational Medicine: A Journey in Science: The Birth of Organ Transplantation with Particular Reference to Alloengraftment Mechanisms.
Starzl T
Mol Med. 2015; 21:227-32.
PMID: 26197024
PMC: 4503646.
DOI: 10.2119/molmed.2014.00254.
The role of everolimus in liver transplantation.
Ganschow R, Pollok J, Jankofsky M, Junge G
Clin Exp Gastroenterol. 2014; 7:329-43.
PMID: 25214801
PMC: 4159129.
DOI: 10.2147/CEG.S41780.
Detection of noncovalent FKBP-FK506 and FKBP-Rapamycin complexes by capillary electrophoresis-mass spectrometry and capillary electrophoresis-tandem mass spectrometry.
Hsieh Y, Cai J, Li Y, Henion J, Ganem B
J Am Soc Mass Spectrom. 2013; 6(2):85-90.
PMID: 24222070
DOI: 10.1016/S1044-0305(94)00097-J.
Prophylaxis of hepatitis B infection in solid organ transplant recipients.
John S, Andersson K, Kotton C, Hertl M, Markmann J, Cosimi A
Therap Adv Gastroenterol. 2013; 6(4):309-19.
PMID: 23814610
PMC: 3667476.
DOI: 10.1177/1756283X13487942.
Contrast-enhanced ultrasound with SonoVue in the evaluation of postoperative complications in pediatric liver transplant recipients.
Bonini G, Pezzotta G, Morzenti C, Agazzi R, Nani R
J Ultrasound. 2013; 10(2):99-106.
PMID: 23396596
PMC: 3478709.
DOI: 10.1016/j.jus.2007.02.008.
Development of a bioartificial liver employing xenogeneic hepatocytes.
Hu W, Friend J, Wu F, Sielaff T, Peshwa M, Lazar A
Cytotechnology. 2012; 23(1-3):29-38.
PMID: 22358518
PMC: 3449881.
DOI: 10.1023/A:1007906512616.
Improving Donor Livers by Inhibiting TNF-α Production.
Zetzmann C, Swamy O, Loss Jr G, Bohorquez H, Cohen A
Ochsner J. 2011; 10(4):250-5.
PMID: 21603393
PMC: 3096233.
Phosphoinositide hydrolysis mediated by H1 receptors in autoimmune myocarditis mice.
Goren N, Leiros C, Sterin-Borda L, Borda E
Mediators Inflamm. 1993; 2(4):317-22.
PMID: 18475540
PMC: 2365419.
DOI: 10.1155/S0962935193000444.
Mechanisms of tumor necrosis factor-alpha and interleukin-6 induction during human liver transplantation.
Hamilton G, Vogel S, Fuegger R, Gnant F
Mediators Inflamm. 1993; 2(4):303-7.
PMID: 18475538
PMC: 2365415.
DOI: 10.1155/S0962935193000420.
Cirrhotic cardiomyopathy.
Baik S, Fouad T, Lee S
Orphanet J Rare Dis. 2007; 2:15.
PMID: 17389039
PMC: 1847677.
DOI: 10.1186/1750-1172-2-15.
Treatment of follicular non-Hodgkin's lymphoma.
Maloney D
Curr Hematol Rep. 2004; 4(1):39-45.
PMID: 15610658
DOI: 10.1007/s11901-005-0025-1.
